Robin Farias-Eisner, MD, PhD
Robin Farias-Eisner, MD, PhD

Robin Farias-Eisner, MD, PhD

Professor
School of Medicine

Academic Appointments

Department

  • Obstetrics & Gynecology

Position

  • Professor

Publications and Presentations

Articles

  • Nava M, Dutta P, Farias-Eisner R, Vadgama JV, Wu Y. Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance. Sci Rep. 2019 Mar 26;9(1):5141. doi: 10.1038/s41598-019-41672-6., Sci Rep, 9(1), 5141, 2019
  • Kaufman M, Cruz A, Thompson J, Reddy S, Bansal N, Cohen JG, Wu Y, Vadgama J, Farias-Eisner R. A review of the effects of healthcare disparities on the experience and survival of ovarian cancer patients of different racial and ethnic backgrounds. J Cancer Metastasis Treat. 2019;5. pii: 13. doi: 10.20517/2394-4722.2018.25. Epub 2019 Feb 27., Journal of Cancer Metastasis and Treatment, 2019;5, 13, 2019

  • Nava M, Dutta P, Zemke NR, Farias-Eisner R, Vadgama JV, Wu Y. Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.
    doi: 10.1186/s12920-019-0477-8.
     , BMC Med Genomics, 12(1), 32, 2019
  • Devarajan A, Su F, Grijalva V, Yalamanchi M, Yalamanchi A, Gao F, Trost H, Nwokedi J, Farias-Eisner G, Farias-Eisner R, Fogelman AM, Reddy ST. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death Dis. 2018 Mar 12;9(3):392. doi: 10.1038/s41419-018-0395-2. PMID: 29531225, Nature, 9(3), 392, 2018
  • Liang MI, Wong DH, Walsh CS, Farias-Eisner R, Cohen JG. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers. J Genet Couns. 2017 Aug 7. doi: 10.1007/s10897-017-0135-2. [Epub ahead of print] PMID: 28785836, J Genet Couns, 2017
  • Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun;163(3):449-460. doi: 10.1007/s10549-017-4211-y. Epub 2017 Mar 23., Breast Cancer Research and Treatment, 163(3), 449-460, 2017
  • Ramadoss S, Sen S, Ramachandran I, Roy S, Chaudhuri G, Farias-Eisner R. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance. Oncogene. 2017 Mar;36(11):1537-1545. doi: 10.1038/onc.2016.320. Epub 2016 Oct 3., Oncogene, 36(11), 157-145, 2016
  • Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G. Cystathionine: A novel oncometabolite in human breast cancer. Arch Biochem Biophys. 2016 Aug 15;604:95-102. doi: 10.1016/j.abb.2016.06.010. Epub 2016 Jun 14., Archives of Biochemistry and Biophysics, 604, 95-102, 2016
  • Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):303-8. doi: 10.1016/j.jmig.2015.12.012. Epub 2016 Jan 8., Journal of Minimally Invasive Gynecology, 54(4), 995-1010, 2016

General

  • Sen S, Kawahara B, Mahata SK, Tsai R, Yoon A, Hwang L, Hu-Moore K, Villanueva C, Vajihuddin A, Parameshwar P, You M, Bhaskar DL, Gomez O, Faull KF, Farias-Eisner R, Chaudhuri G. Cystathionine: A novel oncometabolite in human breast cancer. Arch Biochem Biophys. 2016 Aug 15;604:95-102. doi: 10.1016/j.abb.2016.06.010. Epub 2016 Jun 14., Archives of Biochemistry and Biophysics, 604, 95-102, 2016

Presentations

  • "Rosie, The Orangutan" Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University September, 2019., 2019
  • "Blood Supply to the Pelvis" Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University August, 2019., 2019
  • Ureteric Injuries in Obstetrics and Gynecology; Grand Rounds; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University July, 2019., 2019
  • Discoveries: From the Research Bench to the Patient Bedside; Resident Research Day; Department of Obstetrics and Gynecology; Creighton University School of Medicine; Creighton University; June, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, April, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, March, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, March, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, January, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, January, 2019., 2019
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight PACHE committee; UCLA, August, 2018., 2018
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 NCI oversight IAC committee; UCLA, July, 2018., 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; UNLV Medical School, Las Vegas; March, 2018., 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; American Hospital of Paris, Paris; March, 2018., 2018
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; University of Utah Medical School, Salt Lake City; November, 2017., 2017
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2017., 2017
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2017., 2017
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, June, 2017., 2017
  • “Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries”; U54 NCI oversight committee; UCLA, April, 2017., 2017
  • Elimination of Healthcare Disparities in a Cancer Cohort - Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; U54 IAC oversight committee; UCLA, February, 2017., 2017
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2016., 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, August, 2016., 2016
  • “A Business-Driven Academic Healthcare System Enterprise Model of Academic Excellence”; Department of Obstetrics and Gynecology; University of Toledo, August, 2016., 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Rutgers Robert Wood Johnson Medical School, August, 2016., 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; University of Toledo, August, 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl and Roberta Deutsch Foundation seminar; Carl and Roberta Deutsch Foundation, Los Angeles, California, July, 2016., 2016
  • Closing the Health Disparities’ Gap in Cancer Care; Direct Clinical Applications of Novel Diagnostic and Therapeutic Discoveries; Department of Obstetrics and Gynecology; Texas Tech Medical School, El Paso; September, 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, June 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, June 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, March 2016., 2016
  • “Investigator-Initiated Clinical Trials”. Carl Deutsch Philanthropist discussion; Carl and Roberta Deutsch Foundation, Los Angeles, California, March 2016., 2016
  • “Novel Diagnostic Platform”; Department of Obstetrics and Gynecology; Grand Rounds; David Geffen School of Medicine at UCLA, Los Angeles, California, January, 2016., 2016
  • “Novel Diagnostic Platform”; Department of Obstetrics and Gynecology; Grand Rounds; David Geffen School of Medicine at UCLA, Los Angeles, California, January, 2016., 2016